Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Proef om FEP-aanwezigheid te verhogen

1 oktober 2026 bijgewerkt door: William Smith, University of Pennsylvania

Financiële stimulansen om de behandelingsaanwezigheid in eerste-episode psychosezorg te vergroten: een niet-gerandomiseerde, adaptieve pilotstudie

Individuals with first-episode psychosis (FEP) are at high-risk for several poor functional and clinical outcomes, including suicide. Coordinated Specialty Care (CSC) is a multidisciplinary, team-based intervention known to improve such outcomes, including suicide risk. However, 30-50% of patients disengage from CSC, thereby limiting its impact. This pilot study will develop and test feasibility of a behavioral change program that uses moderate financial incentives to encourage treatment engagement in 2 CSC programs. A single-arm of 80 patient-participants at these two clinics will be recruited to assess feasibility and acceptability from patient perspectives. Additionally,15 clinicians at these two clinics will be recruited to assess feasibility and acceptability from clinician perspectives, and 50 clinicians from peer clinics not involved in the intervention will be recruited to assess scalability of the intervention. The trial will feature an three-month period for recruitment and baseline data collection and will subsequently feature three intervention periods (3 months each) where modifications to the interventions will be tested (each informed by the feasibility and acceptability findings of the prior period) with the aim of sequentially improving it.

Studie Overzicht

Toestand

Actief, niet wervend

Studietype

Ingrijpend

Inschrijving (Geschat)

145

Fase

  • Vroege fase 1

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • North Carolina
      • Raleigh, North Carolina, Verenigde Staten, 27608
        • University of North Carolina at Chapel Hill (ENCOMPASS Program)
    • Pennsylvania
      • Philadelphia, Pennsylvania, Verenigde Staten, 19123
        • PEACE Program, Horizon House, Inc.
      • Philadephia, Pennsylvania, Verenigde Staten, 19104
        • University of Pennsylvania

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  1. For all participants, age ≥ 18 years old.
  2. For intervention trial and patient feasibility and acceptability measurement: Patients with first-episode psychosis, enrolled in Coordinated Specialty Care at the Psychosis Education, Assessment, Care and Empowerment (PEACE) clinic and Psychosis Evaluation and Recovery Center (PERC).
  3. For clinician feasibility and acceptability measurement at intervention sites: Clinicians working at PEACE and PERC where the intervention will be piloted.
  4. For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: Clinicians in Connection LHS who work at sites other than PEACE and PERC.Participants must sign the informed consent form

Exclusion Criteria:

  1. For intervention trial and patient feasibility and acceptability measurement: Expectation of leaving coordinated specialty care programing within 6 months (which will exclude all of the PI's patient panel) and/or intellectual disability of sufficient degree that the patient's primary psychiatrist expects to compromise capacity to consent to this research and/or psychosis secondary to another medical condition (which may not share the same motivational features that are otherwise understood about the primary psychiatric conditions with psychosis).
  2. For clinician feasibility and acceptability measurement at intervention sites: Study investigators who work at these clinics will be excluded from participation in the feasibility and acceptability study component given their role in the trial planning and execution.
  3. For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: none.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Niet-gerandomiseerd
  • Interventioneel model: Opdracht voor een enkele groep
  • Masker: Geen (open label)

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Acceptability of intervention measure (AIM)
Tijdsspanne: Change at 8 months

The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20.

Change at 8 months
Acceptability of intervention measure (AIM)
Tijdsspanne: Change at 6 months

The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20.

Change at 6 months
Acceptability of intervention measure (AIM)
Tijdsspanne: Change at 4 months

The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20.

Change at 4 months
Feasibility of intervention measure (FIM)
Tijdsspanne: Change at 8 months

The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20.

Change at 8 months
Feasibility of intervention measure (FIM)
Tijdsspanne: Change at 6 months

The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20.

Change at 6 months
Feasibility of intervention measure (FIM)
Tijdsspanne: Change at 4 months

The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20.

Change at 4 months

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Implementation Survey Response
Tijdsspanne: Change at 8 months

Implementation survey. Results will be used to optimize intervention from implementation perspective.

Change at 8 months
Implementation Survey Response
Tijdsspanne: Change at 6 months

Implementation survey. Results will be used to optimize intervention from implementation perspective.

Change at 6 months
Implementation Survey Response
Tijdsspanne: Change at 4 months

Implementation survey. Results will be used to optimize intervention from implementation perspective.

Change at 4 months
Motivation Survey Response
Tijdsspanne: Change at 8 months

Motivation survey. Results will be used to optimize intervention from motivation perspective.

Change at 8 months
Motivation Survey Response
Tijdsspanne: Change at 6 months

Motivation survey. Results will be used to optimize intervention from motivation perspective.

Change at 6 months
Motivation Survey Response
Tijdsspanne: Change at 4 months

Motivation survey. Results will be used to optimize intervention from motivation perspective.

Change at 4 months
Ethical Concern Survey Response
Tijdsspanne: Change at 8 months

Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective.

Change at 8 months
Ethical Concern Survey Response
Tijdsspanne: Change at 6 months

Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective.

Change at 6 months
Ethical Concern Survey Response
Tijdsspanne: Change at 4 months

Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective.

Change at 4 months

Andere uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
attrition
Tijdsspanne: Change at 8 months

rate of attrition

Change at 8 months
attrition
Tijdsspanne: Change at 6 months

rate of attrition

Change at 6 months
attrition
Tijdsspanne: Change at 4 months

rate of attrition

Change at 4 months
psychotic symptomology
Tijdsspanne: Change at 8 months

Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology.

Change at 8 months
psychotic symptomology
Tijdsspanne: Change at 6 months

Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology.

Change at 6 months
psychotic symptomology
Tijdsspanne: Change at 4 months

Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology.

Change at 4 months
psychotic symptomology
Tijdsspanne: Change at 8 months

modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology.

Change at 8 months
psychotic symptomology
Tijdsspanne: Change at 6 months

modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology.

Change at 6 months
psychotic symptomology
Tijdsspanne: Change at 4 months

modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology.

Change at 4 months
depression
Tijdsspanne: Change at 8 months

abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology)

Change at 8 months
depression
Tijdsspanne: Change at 6 months

abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology)

Change at 6 months
depression
Tijdsspanne: Change at 4 months

abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology)

Change at 4 months
quality of life
Tijdsspanne: Change at 8 months

4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life)

Change at 8 months
quality of life
Tijdsspanne: Change at 6 months

4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life)

Change at 6 months
quality of life
Tijdsspanne: Change at 4 months

4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life)

Change at 4 months
recovery
Tijdsspanne: Change at 8 months

5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery)

Change at 8 months
recovery
Tijdsspanne: Change at 6 months

5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery)

Change at 6 months
recovery
Tijdsspanne: Change at 4 months

5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery)

Change at 4 months
treatment motivation (intrinsic versus extrinsic)
Tijdsspanne: Change at 8 months

Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5.

Change at 8 months
treatment motivation (intrinsic versus extrinsic)
Tijdsspanne: Change at 6 months

Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5.

Change at 6 months
treatment motivation (intrinsic versus extrinsic)
Tijdsspanne: Change at 4 months

Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5.

Change at 4 months
Perceived coercion
Tijdsspanne: Change at 8 months

Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others.

Change at 8 months
Perceived coercion
Tijdsspanne: Change at 6 months

Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others.

Change at 6 months
Perceived coercion
Tijdsspanne: Change at 4 months

Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others.

Change at 4 months
attendance rate
Tijdsspanne: Change over 8 months

number of appointments attended in a given period divided by number of appointments scheduled

Change over 8 months
attendance rate
Tijdsspanne: Change at 6 months

number of appointments attended in a given period divided by number of appointments scheduled

Change at 6 months
attendance rate
Tijdsspanne: Change at 4 months

number of appointments attended in a given period divided by number of appointments scheduled

Change at 4 months

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 februari 2025

Primaire voltooiing (Werkelijk)

18 december 2025

Studie voltooiing (Geschat)

31 december 2026

Studieregistratiedata

Eerst ingediend

20 juni 2023

Eerst ingediend dat voldeed aan de QC-criteria

28 juli 2023

Eerst geplaatst (Werkelijk)

1 augustus 2023

Updates van studierecords

Laatste update geplaatst (Werkelijk)

6 oktober 2026

Laatste update ingediend die voldeed aan QC-criteria

1 oktober 2026

Laatst geverifieerd

1 oktober 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • 2023-03

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren